Alzheimer’s researchers seethe over years of missteps after latest drug failure
(By Sharon Begley for STAT) In the wake of disappointing results this week for yet another experimental Alzheimer’s drug, scientists who
Read More(By Sharon Begley for STAT) In the wake of disappointing results this week for yet another experimental Alzheimer’s drug, scientists who
Read More(By Eric Boodman for STAT) The herbal supplement seemed like a miracle. Trying to kick an opioid addiction, the middle-aged
Read More(By Dylan Scott for STAT) PHILADELPHIA — The drug industry didn’t really feel the heat here at the Democratic National
Read More(By Ed Silverman for STAT) Faced with budgetary constraints, England’s National Health Service took several controversial steps to delay coverage
Read More(By Andrew Joseph for STAT) Several teams of scientists are racing to develop a vaccine for the Zika virus. But
Read MoreThe Food and Drug Administration approved Probuphine (used in treatment of drug additions) under the condition that physicians are trained
Read MoreCombating antibiotic Resistant Bacteria Biopharmaceutical Accelerator or Carb-X for short is bringing together the United States and British health officials,
Read More(By Anna Vlasits for STAT) Humans, and the microbes that live inside us, could be the source of the next
Read More(By Damian Garde for STAT) A closely watched treatment for Alzheimer’s disease came up short in a late-stage trial, marking the
Read More(By Brooke Murphy for Becker’s Hospital Review) Hepatitis C drug Harvoni topped the list of Medicare’s priciest prescription drugs in
Read More